Clinical Trial Details
EORTC-08983
Back to Clinical Trials Database
Phase III study of Tomudex and Cisplatin versus Cisplatin in Malignant Pleural Mesothelioma.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 26-Nov-1999 Date Step1 close: 06-Jan-2003 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 240 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00004920 |
NCT number | NCT00004920 |